Skip to content

The Impact of a Moderate Carbohydrate Diet in Children With Type 1 Diabetes on Hybrid Closed-loop Therapy

The Impact of Carbohydrate Restriction on Glycemic Control in Children and Adolescents With Type 1 Diabetes Using a Hybrid Closed-loop Insulin Delivery System: a Randomized Cross-over Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06567158
Acronym
COMBINE1
Enrollment
28
Registered
2024-08-22
Start date
2024-05-15
Completion date
2025-12-31
Last updated
2024-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 1

Brief summary

In the past, carbohydrate restriction was indicated as a treatment for people with type 1 diabetes when exogenous insulin was not available. Now it is mainly used as an added treatment for people with type 1 diabetes on top of standard insulin administration and glucose monitoring. Despite previous studies, the impact of carbohydrate restriction on glycemic control and quality of life is still not clear. Furthermore, few studies exist on carbohydrate restriction in children with type 1 diabetes and combined with the use of hybrid closed-loop insulin delivery. Therefore this study will determine the impact on glycemic control and the feasability of a moderate carbohydrate diet compared to a traditional diet in children (7-17 years) with type 1 diabetes on top of using a hybrid closed-loop system. In this randomized, crossover study, 28 children will follow a moderate carbohydrate diet (four weeks) and a traditional diet (four weeks) in randomized order. With a run-in period (two weeks) prior to the first diet and a wash-out period (six weeks) between the two diets, the children will participate in the study for a total of 16 weeks. The primary endpoint is the difference of time spent in target range (defined as a sensor glucose value between 70 and 180 mg/dL) between the four-week moderate carbohydrate diet and the four-week traditional diet.

Interventions

During the moderate carbohydrate diet, participants will be asked to limit his/her carbohydrate intake to no more than 30% of their total energy intake.

During the traditional diet, participants do not follow any diet, however their carbohydrate intake must be at least 50% of their total energy intake.

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The study will be preceded by a screening period to check which participants are eligible for the study and a two-week run-in period during which, participants will be asked to document their eating patterns for one week in a digital food diary to base the moderate carbohydrate diet on. Participants will be randomized into two groups (1:1). One group will start at baseline with the traditional diet and after four weeks they will cross-over to the moderate carbohydrate diet for four weeks. The second group will start at baseline with the moderate carbohydrate diet and after four weeks they will crossover to the traditional diet for four weeks. Between the two diet periods there will be a wash-out period of six weeks.

Eligibility

Sex/Gender
ALL
Age
7 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Signed informed consent (ICF) (both children/adolescents and parents) * ≥7 and ≤17 years old at moment of ICF signature * ≥6 months type 1 diabetes diagnosis at moment of ICF signature * ≥3 months use of the hybrid closed-loop system Medtronic MiniMedTM 780G, Tandem t:slim X2 Control-IQTM or Mylife Ypsopump with CamAPS algorithm at moment of ICF signature * Ability to understand, read, write and speak Dutch, French or English at moment of ICF signature

Exclusion criteria

* \<7 or \>17 years old at moment of ICF signature * \<6 months type 1 diabetes diagnosis at moment of ICF signature * \<3 months use of the advanced hybrid closed-loop system Medtronic MiniMedTM 780G, Tandem t:slim X2 Control-IQTM or Mylife Ypsopump with CamAPS algorithm at moment of ICF signature * Any other insulin therapy than advanced hybrid closed-loop system Medtronic MiniMedTM 780G , Tandem t:slim X2 Control-IQTM or Mylife Ypsopump with CamAPS algorithm at moment of ICF signature * Failure to understand, read, write or speak Dutch, French or English at moment of ICF signature

Design outcomes

Primary

MeasureTime frameDescription
Time in range4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference of time spent in range (70-180 mg/dL) between the moderate carbohydrate diet and the traditional diet.

Secondary

MeasureTime frameDescription
Time below range4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference of time spent below range (\<70 mg/dL) between the moderate carbohydrate diet and the traditional diet.
Time in level 2 hypoglycemia4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference of time spent below range of 54 mg/dL between the moderate carbohydrate diet and the traditional diet.
Time above range4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference of time spent above range (\>180 mg/dL) between the moderate carbohydrate diet and the traditional diet.
Time in level 2 hyperglycemia4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference of time spent above range of 250 mg/dL between the moderate carbohydrate diet and the traditional diet.
Hemoglobin A1c4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference of hemoglobin A1c between the moderate carbohydrate diet and the traditional diet.
Mean blood glucose4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference of mean blood glucose between the moderate carbohydrate diet and the traditional diet.
Glycemic variability: standard deviation and coefficient of variation4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference of glycemic variability, in terms of standard deviation (SD) and coefficient of variation (CV) of blood glucose levels between the moderate carbohydrate diet and the traditional diet.
Daily insulin dose4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference of insulin doses (total, basal and bolus) between the moderate carbohydrate diet and the traditional diet.
Number of severe hypoglycemic events4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference in the frequency of severe hypoglycemic events between the moderate carbohydrate diet and the traditional diet.
Number of diabetic ketoacidosis4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference in the frequence of diabetic ketoacidosis between the moderate carbohydrate diet and the traditional diet.
Time in tight range4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference of time spent in range (70-140 mg/dL) between the moderate carbohydrate diet and the traditional diet.
Body mass index4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference in body mass index between the moderate carbohydrate diet and the traditional diet.
Blood lipids (total cholesterol, triglycerides, high density lipoprotein and low density lipoprotein concentrations)4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference in blood lipids (total cholesterol, triglycerides, high density lipoprotein and low density lipoprotein concentrations) between the moderate carbohydrate diet and the traditional diet.
Satisfaction with the diet in the context of diabetes treatment4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference in the satisfaction with the diet (Diabetes treatment satisfaction questionnaire - DTSQs) between the moderate carbohydrate diet and the traditional diet. The DTSQs has a scale of 0-48 and a higher score is associated with a higher treatment satifaction.
Bioelectrical impedance analysis4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference in bioelectrical impedance analysis between the moderate carbohydrate diet and the traditional diet.
Carb ratio4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference in carb ratio between the moderate carbohydrate diet and the traditional diet.
Active insulin time4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference in active insulin time between the moderate carbohydrate diet and the traditional diet.
Number of people who use glucose target 100 mg/dL, 110 mg/dL and 120 mg/dL4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference in umber of people who use glucose target 100 mg/dL, 110 mg/dL and 120 mg/dL between the moderate carbohydrate diet and the traditional diet.
Consumed carbohydrates4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference in consumed carbohydrates between the moderate carbohydrate diet and the traditional diet.
Meal composition4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference in meal composition a between the moderate carbohydrate diet and the traditional diet.
Body weight4 weeks moderate carbohydrate diet and 4 weeks traditional dietDifference in body weight between the moderate carbohydrate diet and the traditional diet.

Countries

Belgium

Contacts

Primary ContactKristina Casteels, Prof
kristina.casteels@uzleuven.be+3216343811
Backup ContactLaura Valgaerts
laura.valgaerts@uzleuven.be+3216343890

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026